Title:
医薬組成物
Document Type and Number:
Japanese Patent JP7228726
Kind Code:
B2
Abstract:
A pharmaceutical composition is described. The composition comprises: (i) a drug component comprising at least one pharmaceutically acceptable salt of glycopyrrolate and at least one long acting beta-2-agonist (LABA) selected from formoterol and the pharmaceutically acceptable salts thereof; and (ii) a propellant component at least 90 weight % of which is 1,1-difluoroethane (HFA-152a).
Inventors:
Stuart Cole
Timothy James Noks
Timothy James Noks
Application Number:
JP2022022292A
Publication Date:
February 24, 2023
Filing Date:
February 16, 2022
Export Citation:
Assignee:
Mexican Flow Ese a de se ve
International Classes:
A61K31/40; A61K9/12; A61K31/167; A61K47/06; A61K47/10; A61K47/12; A61K47/24; A61K47/32; A61K47/34; A61M15/00; A61P11/00; A61P43/00
Domestic Patent References:
| JP2014528470A | ||||
| JP2014505717A | ||||
| JP2014513146A |
Attorney, Agent or Firm:
Masaharu Takamura
Yu Hasegawa
Yu Hasegawa
Previous Patent: Display device
Next Patent: NON-STAINING COMPOSITION FOR COLORED TIRE RUBBER AND PROTECTIVE MATERIAL
Next Patent: NON-STAINING COMPOSITION FOR COLORED TIRE RUBBER AND PROTECTIVE MATERIAL